Skip to main content

Aptevo Therapeutics Inc. Common Stock (APVO)

About The Company

APVO Stock Market Logo

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific,and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

IPO Year Sector Industry
N/A Health Care Biotechnology: Pharmaceutical Preparations

Aptevo Therapeutics Inc. (APVO) Latest News

Company Contact & Address (APVO)

Corporate Headquarters Phone Website
2401 4TH AVENUE SUITE 1050,
United States
+1 206 838-0500 Official APVO Website

APVO Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ APVO

Jobs & Employment at Aptevo Therapeutics Inc.

LinkedIn Company Page
Official Career & Employment Page Employment, Jobs & Careers at Aptevo Therapeutics Inc. (APVO)

Related & Similar Stock Symbols

NYMTZ Stock Market Price & News


New York Mortgage Trust Inc. 7.000% Series G …

LND Stock Market Price & News


Brasilagro Brazilian Agric Real Estate Co Sponsored …

FICVU Stock Market Price & News


Frontier Investment Corp Units